Trial intelligence / Profile preview

Isradipine for Buprenorphine Detoxification

NCT01895270Phase 2Completed

Sponsor
University of Arkansas
Start
Oct 2013
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Isradipine in opioid use disorder (OUD), sponsored by University of Arkansas. Started Oct 2013; status: completed.

02

Drugs

Isradipine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT01895270.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01895270.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call